Recent Event Highlights: Watson Pharmaceuticals Powers a Continuous Learning Environment with Blackboard Learn, Mancow Discusses Pharmaceuticals Being Added to Water Supplies on The Alex Jones Show, Earnings Report: Watson Pharma Tops Q2 EPS and Revenue Estimates, Guides Full-Year Inline, Mancow Discusses Pharmaceuticals Being Added to Water Supplies on The Alex Jones Show, The Fly On The Wall Morning Market Snapshot: June 18, 2010, Watson Pharma at AUA 2010, and 61 more...
Created by dipity on Jun 17, 2009
Last updated: 01/19/11 at 07:57 PM
Watson Pharmaceuticals has no followers yet. Be the first one to follow.
California-based Watson Pharmaceuticals Inc. takes innovative steps to prepare its sales force. With three product launches in the same specialty on the way, all eyes were on Watson, the nation's third-largest prescription drug provider.
Popular radio host Mancow also joins the show to discuss pharmaceuticals being added to water supplies. www.mancow.com www.infowars.com www.prisonplanet.tv
Watson Pharmaceuticals (NYSE:WPI)reported Q2 EPS of $0.83, topping consensus estimates of $0.81 per share. Revenues rose 29% year-over-year to $875.3 million, topping estimates of $860.6 million. The company sees full year EPS of $3.30-$3.45 on revenues of $3.5 billion, vs. consensus estimates of $3.38 per share on revenues of $3.53 billion. Paul Bisaro, President and CEO, said, "We continue to emphasize growing our businesses through product development and portfolio and market expansion. In the US, we have launched five new generic products so far this year and announced twelve new patent challenges. Outside the US, we continue to focus on enhancing our management structure, the profitability of our country operations, and expanding our presence in all of our markets including Finland, Poland and Turkey. We also invested more than $44 million in generic R&D, an increase of 49 percent." SmarTrend currently has Watson Pharmaceuticals in a downtrend and is currently monitoring these developments and will alert subscribers to any change of trend.
Popular radio host Mancow also joins the show to discuss pharmaceuticals being added to water supplies. www.mancow.com www.infowars.com www.prisonplanet.tv
Good Morning. It's Friday, June 18, 2010. At this hour, US equity futures are lower. Overseas, the Asian markets were mixed, while the European markets are also mixed. Danone (DANOY) and Unimilk announced an agreement to merge Danone's Fresh Dairy Product businesses in the CIS area with those of Russian company Unimilk...HRA Pharma announced that an FDA Advisory Committee for Reproductive Health Drugs voted 11-0 that the company and Watson Pharmaceuticals (WPI) application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive. The drug would be a rival to Teva's (TEVA) Plan B morning-after pill...Crexus (CSX) raises its dividend to 12c from 7c per share, payable July 28 to common shareholders of record on June 28. The ex-dividend date is June 24...Alkermes (ALKS) announced that the FDA notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, for the review of the company's supplemental New Drug Application for VIVITROL for opioid dependence.
Watson Pharmaceuticals @ the American Urological Association (AUA) 2010 show in San Francisco, CA at the Moscone Center. This is a quick video detailing the setup of their 50' x 80 custom exhibit - including footage during the show.
Watson Pharmaceuticals tries to have the best of both worlds, with operations in the US generics market and the higher-profit-margin branded drug business. The company's broad generics portfolio of about 140 products includes treatments for hypertension and pain, as well as smoking cessation products, antidepressants, and oral contraceptives. Its line of about 25 branded drugs focuses on urology and nephrology; it markets its branded products, including treatments for iron deficiency anemia and overactive bladder, to specialist physicians in the US. Additionally, Watson distributes its own and third-party products to independent pharmacies and health care providers through its Anda and Valmed subsidiaries
Good Morning. It's Tuesday, May 25, 2010. At this hour, US equity futures are lower. Overseas, the Asian markets retreated, while the European markets are down. (NTRS) initiated with a Hold at Jefferies...Bank of New York Mellon (BK) initiated with a Hold at Jefferies. Hot News: Cliffs Natural Resources (CLF) announced that it intends to make take-over bids pursuant to which Cliffs or an affiliate would acquire all of the common shares of each of KWG Resources and/or Spider Resources not owned by Cliffs or its affiliates. Neither of the proposed take-over bids, which will be funded with Cliffs existing cash resources, is conditional on the completion of the other...Avnet (AVT) announced that, through its wholly-owned indirect subsidiary Avnet EM Holdings Godo Kaisha, it has launched a tender offer bid for all issued shares of Unidux, Inc, a publicly traded company, substantially expanding its presence and customer base in the Japanese market...Boston Scientific (BSX) announced CE Mark and the FDA approval of its NC Quantum Apex PTCA Dilatation Balloon Catheter...Watson Pharmaceuticals (WPI) subsidiary Watson Laboratories has received approval from the FDA for its abbreviated new drug application, or ANDA, for Valacyclovir Hydrochloride tablets, USP, in the 500mg and 1000mg strengths, the generic equivalent to GlaxoSmithKline (GSK)'s Valtrex tablets. Watson intends to begin shipping the product shortly...FMC's (FMC) FMC Wyoming will increase off-list soda ash prices by $10 ...
May 20, 2010 -- Watson Pharmaceuticals (WPI) has received the green light from Canadian regulators to market a generic version of Pfizer's (PFE) drug Lipitor, the Associated Press reported. That comes on top of news yesterday that privately held generic drug maker Apotex said it would also launch a generic version of Lipitor in Canada, Reuters reported. Pfizer has said it will fight the release of that drug. Pfizer shares are down $0.38, or 2.4%, to $15.44. Watson shares are down 1.5%, or $0.65, to $43.08.
VeriSign (VRSN) announced a definitive agreement to sell its authentication services business to Symantec Corp. (SYMC) for about $1.28B in cash...Watson Pharmaceuticals (WPI) subsidiary Cobalt Pharmaceuticals received a notice of compliance from Health Canada to market Atorvastatin Calcium tablets in 10, 20, 40 and 80mg strengths...Staples (SPLS) CEO Ron Sargent says "the year is off to a good start." Staples assumes modest economic recovery in 2010...Procter & Gamble (PG) and PFSweb (PFSW) announced that a new online shopping site is now available for US consumers. Named the eStore, the online shopping site is owned and operated by PFSweb and will feature the breadth of P&G brands...Wells Fargo (WFC) and Visa (V) announced the roll out of Rapid Alerts for Wells Fargo Visa credit cardholders.
USstock futures are trading higher Monday after European leaders agreed to a nearly $1 trillion rescue plan to avoid a major debt crisis. The euro-zone and the IMF agreed to create the new rescue plan to support European countries that are suffering from heavy debt. The Federal Reserve said it would also provide loans overseas. In corporate news, Watson Pharmaceuticals (NYSE:WPI) topped estimates with first-quarter EPS of $0.81, vs. consensus estimates of $0.74 and revenues of $857 million, over estimates of $829 million. Dynegy (NYSE:DYN) reported first-quarter EPS of $0.24 on revenues of $858 million. Dish Network (NASDAQ:DISH) reported better-than-expected EPS of $0.52, over estimates of $0.50, while revenues rose 5% to $3.1 billion. The Dow Jones Industrial Average (DJI) futures are trading 375.00 above fair value, the S&P500 (INX) futures are trading 48.80 points above fair value, and the Nasdaq Composite (IXIC) futures are trading 78.75 points above fair value.
Freddie Mac asked for $10.6B in federal aid from the US Treasury as the weak housing market continued to adversely affect the company's balance sheet...Watson Pharmaceuticals (WPI) confirmed Eli Lilly (LLY) Evista patent challenge as their subsidiary, Watson Laboratories, filed an abbreviated new drug application with the FDA seeking approval to market a raloxifene hydrochloride tablet, a generic version of Evista. Lilly filed suit against Watson on May 3 in the US District Court in Indiana to prevent Watson from commercializing its product prior to the expiration of its US patents...Savient Pharmaceuticals (SVNT) announced that its board determined that a sale of Savient post-approval of KRYSTEXXA by the FDA, assuming approval, would be the best way to realize the full commercial potential of KRYSTEXXA on a global basis and would be the optimal outcome for the company's shareholders and other stakeholders...Endo Pharma (ENDP) will acquire Healthtronics (HTRN) for $223M...American Airlines (AMR) reached a tentative agreement with TWU on Mechanic work group.
At this hour, US equity futures are trading higher. Overseas, the Asian markets were mixed , while the European markets are up. Today's UPGRADES include: Starbucks (SBUX) upgraded to Buy from Neutral at UBS...Sonic (SONC) upgraded to Overweight from Underweight at Piper Jaffray...Clorox (CLX) upgraded to Overweight from Equal Weight at Barclays. DOWNGRADES: Psychiatric Solutions (PSYS) downgraded to Market Perform from Outperform at Wells Fargo...Sequenom (SQNM) downgraded to Underweight from Equal Weight at Stephens...Superior Well Services (SWSI) downgraded to Equal Weight from Overweight at Stephens. Hot News: Eli Lilly (LLY) will acquire a global license for Axiron testosterone solution from Acrux. Watson Pharmaceuticals (WPI) announced that it has received approval from the FDA for its Abbreviated New Drug Application for Dil-tia-zem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail's (BVF) Car-di-zem LA product. Watson intends to launch its generic version of Cardizem(R) LA immediately. Akamai Technologies (AKAM) announced it has been selected as the primary content delivery network for movies and TV episodes streamed instantly over the Internet by Netflix (NFLX). Biolase Technology (BLTI) announced that it has received 510000 clearance from the FDA to market its iLase diode laser, the world's first personal laser for dentists and hygienists for performing a full-range of minimally invasive soft-tissue and hygiene procedures. A new ...
Shares of Watson Pharmaceuticals (NYSE:WPI) are trading 1.3% higher to $40.82 after hours Monday after the company announced that its subsidiary, Watson Laboratories, Inc. - Florida, has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately. Diltiazem Hydrochloride Extended-Release tablets are indicated for the treatment of hypertension. In 2009, Cardizem® LA had total US sales of approximately $94.1 million, according to IMS Health.
Watson Pharmaceuticals base could hold promise, but its fundamentals also offer clues.
Citigroup analysts maintain "buy" rating for Watson Pharmaceuticals (NYSE:WPI), with a $48 price target, and expect outperformance in Q4. Analysts John Boris said, "We expect strong generic Toprol XL (25mg; & 50mg sold in bottles of 1000 vs. PRX's AG in bottles of 100), generic Plan B (sold as Next Choice), as well their Micro-K monopoly position coupled with WPI's shift of products to Goa, India to drive another quarter of outperformance. We assume Arrow contributes ~$41M in 4Q09E sales since the 12/2/09 close of the acquisition. We look for further clarity on FDA action on Toprol XL (100mg/200mg) & Cardizem LA." Citigroup sees 2009 EPS of $2.60, vs. the consensus estimates of $2.56, and 2010 EPS of $3.52, vs. the consensus estimates of $3.28.
Sterling Professor of Molecular Biophysics and Biochemistry, HHMI Investigator, and recipient of the 2009 Nobel Prize for Chemistry Thomas A. Steitz, Ph.D., gives his Nobel Lecture, which he first delivered at Stockholm University on December 8, two days before receiving the Nobel Prize from Swedens King Carl XVI Gustaf.
美國能放幾個胚胎？ Fertility Guidelines Updated on Number of Embryos to Be Transferred During In Vitro Fertilization Fran Lowry Authors and Disclosures Physician Rating: ( 3 Votes ) Rate This Article: Print This Email this INFORMATION FROM INDUSTRY Advances in understanding osteoclast-induced bone loss The RANK-Ligand Pathway appears to be an essential mediator of osteoclast-induced bone loss in postmenopausal osteoporosis. Read more October 20, 2009 — The American Society for Reproductive Medicine (ASRM) and the Society for Assisted Reproductive Technology (SART) have released new guidelines for the number of embryos to be transferred in in vitro fertilization cycles in an effort to reduce high-risk multiple pregnancies. The guidelines, based on ASRM and SART data from 2007, were published online October 19 in Fertility and Sterility. "High-order multiple pregnancy (three or more implanted embryos) is an undesirable consequence (outcome) of assisted reproductive technologies (ART)," the guidelines state. "Multiple gestations lead to an increased risk of complications in both the fetuses and the mothers." The guidelines are meant to assist ART programs and patients to determine the appropriate number of cleavage-stage (usually 2 or 3 days after fertilization) embryos or blastocysts (usually 5 or 6 days after fertilization) to transfer, and they can be modified according to the patient's age, embryo quality, and the opportunity for cryopreservation. They may also be ...
2012: THE RETURN OF CAMELOT -- DAVID WILCOCK's wonderful and inspired closing presentation at the Project Camelot Awake and Aware Conference, Los Angeles, 20 September 2009. -- A note of apology: we did the best we could with the colorizing of the video. The lighting conditions for the camera were very poor (David preferred the conference room lights turned right down so as to emphasize his slide presentation). The value of the content, of course, is unaffected :) PROJECT CAMELOT projectcamelot.org .
Director of the White House Office on Health Reform Nancy-Ann DeParle hosts a discussion with key stakeholders, from businesspeople to health professionals, on health care at the White House. April 8, 2009 (Public Domain)
The DEA-Sativex connection by investigative reporter JessE. The Drug Enforcement Administration/US Government connection with Sativex. "Sam and Nevil use to work a bit on strains together but when it was revealed that Sam and his crew of Americans in Holland all were part of informants for the DEA in America on a radio program in Holland they split to the UK to do other things. Sam never started or owned a seed company so his claim to all the strains that became famous years ago are not really warranted. "-Shantibaba www.overgrow-italy.nl However, no US researcher has imported HortaPharm's marijuana because of refusal by the Dutch authorities to issue an export permit,despite the issuance of an import permit by the DEA ( D. Pate, HortaPharm, personal communication, 1998) www.tc.columbia.edu Under DEA regulations, marijuana can be imported, provided that the researcher is registered with the DEA, has approval for marijuana research (21 CFR § 1301.11, .13, and .18), and has a DEA-approved permit for importation (21 CFR § 1312.11, .12, and .13), and that the exporter in the foreign country has appropriate authorization by the country of exportation. Importation would enable US researchers to conduct research on marijuana grown by HortaPharm, a company that has developed unique strains of marijuana. However, no US researcher has imported HortaPharm's marijuana because Dutch authorities have refused to issue an export permit, despite the issuance of an import permit by the DEA ...
Consumer prices rose less than expected in May and posted the steepest annual drop in 59 years, according to government data today, fresh evidence that the recession is keeping inflation in check. Low prices will make it easier for the Fed to keep a key short-term interest rate near zero, where it has been since December. FedEx, the nation's second largest package shipper, lost more money in the last quarter, as consumers and businesses downsized shipments and the company took over $1 billion in one-time charges. In April, rival UPS said its first-quarter profit plunged 55 percent while it offered a disappointing second-quarter outlook too. Ten large US banks will finish repaying about $68 billion in bailout money today, marking a new phase for the most visible government effort to relieve the credit crisis. With today's repayments, Treasury will have recovered more than $70 billion distributed under the program. And the streak continues campers - Retail gas prices climbed for the 50th straight day today while crude prices that had slumped all week bounced back.. US mortgage applications fell for a fourth consecutive week, with overall demand plunging to its lowest level in nearly seven months. A rise in mortgage rates in recent weeks has sapped demand, particularly for home loan refinancing. Watson Pharmaceuticals said today that it would buy privately held Arrow Group for $1.75 billion, clinching a long-expected deal by the US generic drugmaker to expand internationally ...
Excerpt
...YORK (Reuters) - Watson Pharmaceuticals Inc (WPI.N) said on Wednesday it will buy privately held Arrow Group for $1.75 billion, clinching a long-expected deal by the U.S. generic drugmaker to expand internationally. In acquiring Arrow, Watson will gain a generic...
Source Info
Reuters
http://feedproxy.google.com/~r/reuters/businessNews/~3/w4_R5OldEl8/idUSTRE55G2QI20090617
Excerpt
...Calif.-based Watson Pharmaceuticals Inc. has issued Worker Adjustment and Retraining Notifications announcing 275 job eliminations at it moves to close its Danbury facility and two other locations in Carmel and Brewster, N.Y. Watson, which hired new management...
Source Info
The Connecticut Post
http://www.connpost.com/business/ci_12596468?source=rss
2008 City of Corona State of the City featuring Mayor Jeff Miller ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
recall are 0.125 and 0.25 mg tablets that were distributed prior to March 31, 2009 and which show an expiration date of September, 2011. Because of the variation in tablet size, these products could contain either more or less than the labeled amount of digoxin. Digoxin has a narrow therapeutic index, which means that small variations in tablet potency could have serious effects. Too much of the drug can cause digoxin toxicity, which can include hypotension and cardiac instability and may ...
Excerpt
...months or until final resolution of the matter before the court, whichever occurs sooner. Based on available information, Watson Pharmaceuticals believes that Watson Laboratories may be the first applicant to file an ANDA for a generic version of Mucinex D...
Source Info
Pharmaceutical Business Review
http://regulatoryaffairs.pharmaceutical-business-review.com/news/watson_files_anda_for_generic_mucinex_d_110609
recall are 0.125 and 0.25 mg tablets that were distributed prior to March 31, 2009 and which show an expiration date of September, 2011. Because of the variation in tablet size, these products could contain either more or less than the labeled amount of digoxin. Digoxin has a narrow therapeutic index, which means that small variations in tablet potency could have serious effects. Too much of the drug can cause digoxin toxicity, which can include hypotension and cardiac instability and may ...
Excerpt
...archived version will be available for 30 days after the live presentations and can be accessed at the same locations. Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic...
Source Info
Freshnews.com
http://www.freshnews.com/node/164764
The Backwood BBQ & Steakhouse Peter Dills Special ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
2006 City of Corona State of the City featuring Mayor Karen Spiegel ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Backwoods BBQ & Steakhouse Peter Dills Special ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Corona Citrus City Grille Peter Dills Special ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Miguel's Restaurant Dos Lagos Peter Dills Special ... "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Corona TGI Fridays Peter Dill Special ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Corona TGI Fridays Peter Dill Special
2007 City of Corona State of the City featuring Mayor Eugene Montanez ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Excerpt
...archived version will be available for 30 days after the live presentation and can be accessed at the same locations. Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and...
Source Info
Freshnews.com
http://www.freshnews.com/node/159721
Every year Bomgar heads out to Vegas or Dallas or wherever for the Help Desk Institute Annual Conference and Expo. This time . . . we documented it. Interviewed in this video are representatives from Memorial Hermann Healthcare Systems, Norton Healthcare, Watson Pharmaceuticals and Interior Health. ... Bomgar Helpdesk "Remote Support" HDI
2009 City of Corona State of the city. Mayor Steve Nolan Presents the Chic-Fil-A Quartet: Star Spangled Banner ... "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
2009 City of Corona State of the city. Mayor Steve Nolan Presents the Chic-Fil-A Quartet: Tribute to the Armed Forces Medley ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Excerpt
...Wednesday, May 27, 2009 at 9:00 a.m. Eastern Daylight Time. This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at ir.watson.com : . The webcast can also be accessed at the following URL: www.corporate-ir.net/ireye/conflobby.zhtml?ticker=WPI&item_i...
Source Info
PR-Inside.com
http://www.pr-inside.com/watson-to-present-at-the-sanford-r1272473.htm
The California High-Speed Rail Authority (CHSRA) proposes high-speed train service for travel between major metropolitan areas of California. The service would run from Los Angeles, Orange County and San Diego in the south and to the San Francisco Bay Area and sacramento in the north. ... "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito" ...
2009 City of Corona State of the City featuring Mayor Steve Nolan ... "City of Corona" "Dos Lagos" "The Crossings" "South Corona" "Mountain Gate" "McKinley Hills" "Sierra del Oro" "Fender Guitar" "Watson Pharmaceuticals" "Troy Lee Design" "Sycamore Creek" "El Cerrito"
Excerpt
...YORK - Watson Pharmaceuticals Inc will continue to sell the Ferrlecit iron deficiency treatment in the United States for the rest of the year following an arbitrator's ruling, the company said on Monday, giving Watson a victory for its closely watched product. Sanofi-Aventis...
Source Info
International Business Times
http://www.ibtimes.com/articles/20090518/watson-sell-iron-treatment-through-end.htm
matter what is true, it only matters what people believe is true." - Paul Watson, co-founder of Greenpeace May 1, 2009 Alan Watt "Cutting Through The Matrix" on RBN: Putting Dent in Non-Event -- Fill in the Swill -- Sue the WHO: "The World is to Sink, Like the Titanic, Stampede the Herd, Whip Up the Panic, Throw Sense Out Window with Logic to Bet On, Creating the Fear of Old Armageddon, Begging to be Saved from Invisible Forces, By the Pharma Priests Owning Medical Resources, Put Us in ...
Greenpeace, referred to in this video. "It doesnt matter what is true, it only matters what people believe is true." - Paul Watson, co-founder of Greenpeace May 1, 2009 Alan Watt "Cutting Through The Matrix" on RBN: Putting Dent in Non-Event -- Fill in the Swill -- Sue the WHO: "The World is to Sink, Like the Titanic, Stampede the Herd, Whip Up the Panic, Throw Sense Out Window with Logic to Bet On, Creating the Fear of Old Armageddon, Begging to be Saved from Invisible Forces, By the ...
peopleforwesternheritage.com Pandemic of panic - After salmonella, bird flu, the Millennium Bug... should we actually be scared this time? - www.dailymail.co.uk - by Christopher Booker - May 1, 2009. Lithium in water 'curbs suicide' - news.bbc.co.uk - May 1, 2009. Farmers fear pigs may get "swine" flu from people - www.reuters.com - by Carey Gillam - May 1, 2009. Fears early drug use could cause flu resistance - news.bbc.co.uk - [Hear top scientist say it's the same as last year's flu.] - May 1 ...
thinning heparin drug in the US after some patients experienced extreme - and in some cases fatal - allergic reactions, after being administered the products. There were similar recalls by other manufacturers of Chinese-sourced heparin in Denmark, Italy, France Germany and Japan, but initial investigations found that only Baxter's heparin vaccines were tainted. The FDA has accused two Chinese manufacturers of being responsible for the production and shipment of the tainted vaccines, ...
thinning heparin drug in the US after some patients experienced extreme - and in some cases fatal - allergic reactions, after being administered the products. There were similar recalls by other manufacturers of Chinese-sourced heparin in Denmark, Italy, France Germany and Japan, but initial investigations found that only Baxter's heparin vaccines were tainted. The FDA has accused two Chinese manufacturers of being responsible for the production and shipment of the tainted vaccines, ...
Update Sources